Abstract
Background
Since 2010, the Advisory Committee on Immunization Practices (ACIP) has recommended that all persons aged ≥6 months receive annual influenza vaccination.
Methods
We analyzed data from the 2015 National Internet Flu Survey (NIFS), to assess knowledge and awareness of the influenza vaccination recommendation and early influenza vaccination coverage during the 2015–16 season among adults. Predictive marginals from a multivariable logistic regression model were used to identify factors independently associated with adults’ knowledge and awareness of the vaccination recommendation and early vaccine uptake during the 2015–16 influenza season.
Results
Among the 3301 respondents aged ≥18 years, 19.6% indicated knowing that influenza vaccination is recommended for all persons aged ≥6 months. Of respondents, 62.3% indicated awareness that there was a recommendation for influenza vaccination, but did not indicate correct knowledge of the recommended age group. Overall, 39.9% of adults aged ≥18 years reported having an influenza vaccination. Age 65 years and older, being female, having a college or higher education, not being in work force, having annual household income ≥$75,000, reporting having received an influenza vaccination early in the 2015–16 season, having children aged ≤17 years in the household, and having high-risk conditions were independently associated with a higher correct knowledge of the influenza vaccination recommendation.
Conclusions
Approximately 1 in 5 had correct knowledge of the recommendation that all persons aged ≥6 months should receive an influenza vaccination annually, with some socio-economic groups being even less aware. Clinic based education in combination with strategies known to increase uptake of recommended vaccines, such as patient reminder/recall systems and other healthcare system-based interventions are needed to improve vaccination, which could also improve awareness.
Keywords: Influenza, Influenza vaccine, Vaccination, Coverage, Adult, Knowledge of influenza vaccination recommendation, National Internet Flu Survey (NIFS), The Advisory Committee on Immunization, Practices (ACIP)
1. Introduction
Influenza is a major cause of morbidity and mortality among adults in the United States [1–4]. Influenza illness burden among healthy adults 18–49 years is an important cause of outpatient medical visits and loss of workdays [5,6]. Influenza vaccination has been shown to be a cost-effective tool for reducing morbidity and mortality associated with influenza among adults [5,7–18].
Prior to 2010, the adult groups recommended for annual vaccination included persons 50 years and older, pregnant women, persons 18–49 years with medical conditions associated with higher risk of complications from influenza infection, healthcare personnel, and close contacts of high-risk persons [19]. Since the 2010–11 influenza season, the Advisory Committee on Immunization Practices (ACIP) has recommended annual influenza vaccination for all persons 6 months of age and older, including healthy adults 18–49 years who were not close contacts of persons at high-risk [1] Healthy adults aged 18–49 year was added to the recommendations in the 2010–11 season given the known significant morbidity and economic impact of influenza in working age adults [1]. In addition, the universal vaccination recommendation also eliminates the need to determine whether each person has one or more specific indications for vaccination and emphasizes the importance of preventing influenza among persons of all ages [1].
Influenza vaccination is the most effective strategy for preventing influenza and its complications; however, vaccination coverage has been suboptimal [1,20–22]. Knowledge and awareness of the influenza vaccination recommendation might be related to vaccination coverage [20,23], but information about levels of knowledge and association between knowledge and vaccination among adult population groups is limited.
Data from the 2015 National Internet Flu Survey (NIFS) were analyzed to assess knowledge and awareness of influenza vaccination recommendation and early vaccination during the 2015–16 season among adults aged ≥18 years in the United States.
2. Methods
The NIFS is an annual survey and collects information about early-season influenza vaccination, and knowledge, attitudes, behaviors, and barriers related to influenza and influenza vaccination in the non-institutionalized U.S. adult population. The 2015 NIFS was conducted for Centers for Diseases Control and Prevention (CDC) by RTI International and GfK Custom Research, LLC during October 29–November 11, 2015. The survey was conducted using a probability-based Internet panel, the GfK KnowledgePanel, designed to be representative of the non-institutionalized U.S. population 18 years or older® [24].
For this ongoing panel, participants are initially chosen by a random selection of telephone numbers and residential addresses. Persons in selected households are then invited by telephone or mail to participate in the web-enabled KnowledgePanel®. For those who agree to participate but do not already have Internet access, both a laptop and Internet access are provided at no cost. The laptop was delivered to the residence of the panel members in exchange for members completing a short survey on a weekly basis. The device is theirs to keep if they remain on the panel for three years. Most members are able to install the hardware without additional assistance, although GfK maintains a telephone technical support line and will, when needed, provide on-site installation. Panel members may contact the panel member support department for questions using a toll-free number. Totally, of the 3301 members who completed the survey, 250 were furnished with devices/internet access by GfK. People who already have computers and Internet service participate using their own equipment.
The 2015 NIFS sampling design was a single-stage stratified sample with oversampling of select subgroups of particular analytical interest. Twelve mutually exclusive design strata were defined as the interaction of two categorical variables—age (18–49 years, 50–64 years, and 65 years and older) and race/ethnicity (Hispanic, non-Hispanic white, non-Hispanic black, and non-Hispanic other/multiple races)—known for all members of the probability-based Internet panel. Independent random samples were selected within each design stratum. A total of 6148 panel members across the 12 design strata were randomly sampled using probabilities of selection inversely proportional to the KnowledgePanel® survey weight (a base weight adjusted for nonresponse) from 42,075 eligible panelists, with a target of 4025 completed surveys. A total of 3301 completed the survey, with a completion rate of 53.7% (unweighted), and 57.6% (weighted).
In the 2015 NIFS, a new question was added to the survey regarding knowledge of the influenza vaccination recommendation that all persons age 6 months and older be vaccinated.
Respondents were asked: “Who do you believe the flu vaccine is recommended for?” The potential answers to the question included: (1) all persons age 13 years and older; (2) only adults age 18 years and older with chronic medical conditions; (3) all persons age 6 years and older; (4) all persons age 6 months and older; (5) persons of any age; (6) none of the above; (7) don’t know. Individuals could select only one response to this question. Persons who stated “(4) all persons age 6 months and older” were considered to have correct knowledge of the influenza vaccination recommendation. Respondents who answered either “(1) all persons age 13 years and older” or “(2) only adults age 18 years and older with chronic medical conditions” or “(3) all persons age 6 years and older” or “(5) persons of any age” were considered to have awareness that there was a recommendation for influenza vaccination, but not the correct knowledge of the recommended age group. Persons who stated either “(6) none of the above” or “(7) don’t know” were considered to have neither knowledge nor awareness of the influenza vaccination recommendation.
To determine influenza vaccination coverage, respondents were asked: “Since July 1, 2015, have you had flu vaccination?” and individuals were considered to have received an influenza vaccination if they reported having received the vaccine since July 1, 2015. Influenza vaccination coverage estimates represent approximately the cumulative proportion of persons vaccinated by the time the survey was conducted [21]. Metropolitan Statistical Areas (MSA) status is categorized as metro and non-metro. Metro includes anyone in a metropolitan areas (having at least one urbanized area of 50,000 or more population plus adjacent territory that has a high degree of social and economic integration with the core as measured by commuting ties) or micropolitan areas (having at least one urban cluster of at least 10,000 but less than 50,000 population, plus adjacent territory that has a high degree of social and economic integration with the core as measured by commuting ties). Non-metro includes anyone living outside of both a metropolitan and micropolitan area.
SAS release 9.3 (SAS Inc. Cary, NC) and SUDAAN 11.0 (RTI, Research Triangle Park, NC) were used to calculate point estimates and 95% confidence intervals for knowledge or awareness of the influenza vaccination recommendation, and early season influenza vaccination coverage. T-tests were used to test for differences in knowledge or awareness of the influenza vaccination recommendation, neither knowledge nor awareness of influenza vaccination recommendation, and vaccination coverage and for each variable. A two-sided significance level of 0.05 was adopted for all statistical tests. All percentages in the tables were weighted estimates and the tests were conducted based on the weighted estimates. Multivariable logistic regression models with predictive marginals were used to identify factors independently associated with knowledge or awareness of the influenza vaccination recommendation, neither knowledge nor awareness of influenza vaccination recommendation, and influenza vaccination coverage among adult populations. We did t-tests for each variable within each column, and the reference group for each variable within each column is shown in Table 4. Independent variables in the models which may be associated with vaccination or awareness of recommendation were selected based on previous studies [20,22–23].
Table 4.
Multivariable logistic regression analysis of factors associated with knowledge and awareness of the influenza vaccination recommendation and vaccination coverage among adults >18 years by demographic characteristics - United States, National Internet Flu Survey 2015.
| Knowledgea of influenza vaccination recommendation |
Awarenessb of influenza vaccination recommendation |
Neither knowledge nor awareness of influenza vaccination recommendation |
Early season influenza vaccination coverage |
|
|---|---|---|---|---|
| Characteristic | % (95% CIc) | % (95% CI) | % (95% CI) | % (95% CI) |
| Age | ||||
| 18–49 yearsd | Reference | Reference | Reference | Reference |
| 50–64 years | 1.00 (0.79, 1.26) | 1.00 (0.92, 1.09) | 1.03 (0.82, 1.30) | 1.17 (1.01, 1.35) |
| 65 years and older | 1.47 (1.13, 1.91) | 0.90 (0.80, 1.02) | 0.95 (0.70, 1.31) | 1.64 (1.40, 1.93) |
| Gender | ||||
| Maled | Reference | Reference | Reference | Reference |
| Female | 1.49 (1.25, 1.77) | 0.99 (0.92, 1.05) | 0.69 (0.57, 0.83) | 1.05 (0.95, 1.16) |
| Race/ethnicity | ||||
| Non-Hispanic white onlyd | Reference | Reference | Reference | Reference |
| Non-Hispanic black only | 0.67 (0.49, 0.92) | 1.15 (1.05, 1.26) | 0.86 (0.65, 1.15) | 0.88 (0.74, 1.03) |
| Hispanic | 0.91 (0.68, 1.21) | 1.06 (0.95, 1.19) | 0.94 (0.69, 1.29) | 1.08 (0.92, 1.27) |
| Non-Hispanic, other or multiple races | 0.78 (0.56, 1.08) | 1.13 (1.02, 1.26) | 0.80 (0.57, 1.12) | 1.02 (0.85, 1.23) |
| Marital status | ||||
| Married/living with partnerd | Reference | Reference | Reference | Reference |
| Widowed/divorced/separated | 1.15 (0.92, 1.44) | 0.96 (0.87, 1.06) | 1.02 (0.80, 1.30) | 0.99 (0.86, 1.14) |
| Never married | 0.95 (0.73, 1.24) | 1.02 (0.92, 1.12) | 0.98 (0.74, 1.28) | 0.88 (0.76, 1.03) |
| Education level | ||||
| High school or lessd | Reference | Reference | Reference | Reference |
| Some college | 1.10 (0.88, 1.37) | 0.97 (0.89, 1.05) | 1.02 (0.82, 1.28) | 1.00 (0.88, 1.15) |
| College degree or higher | 1.37 (1.10, 1.70) | 0.93 (0.85, 1.01) | 0.90 (0.71, 1.14) | 1.32 (1.16, 1.49) |
| Employment | ||||
| Employedd | Reference | Reference | Reference | Reference |
| Unemployed | 1.02 (0.65, 1.59) | 1.10 (0.96, 1.26) | 0.68 (0.43, 1.06) | 0.96 (0.75, 1.24) |
| Not in work force | 1.04 (0.84, 1.29) | 0.95 (0.87, 1.04) | 1.11 (0.87, 1.41) | 0.93 (0.82, 1.06) |
| Annual incomee | ||||
| <$35,000d | Reference | Reference | Reference | Reference |
| $35,000–$49,999 | 1.36 (0.99, 1.86) | 1.02 (0.90, 1.16) | 0.71 (0.52, 0.98) | 1.02 (0.85, 1.21) |
| $50,000–$74,999 | 1.15 (0.86, 1.52) | 1.10 (0.99, 1.22) | 0.67 (0.50, 0.89) | 1.13 (0.97, 1.31) |
| $75,000+ | 1.32 (1.00, 1.73) | 1.05 (0.94, 1.16) | 0.68 (0.53, 0.88) | 1.03 (0.89, 1.18) |
| Region of residence | ||||
| Northeastd | Reference | Reference | Reference | Reference |
| Midwest | 0.97 (0.75, 1.26) | 0.95 (0.85, 1.05) | 1.29 (0.96, 1.73) | 1.00 (0.86, 1.17) |
| South | 1.08 (0.86, 1.36) | 0.96 (0.87, 1.05) | 1.08 (0.81, 1.43) | 0.98 (0.85, 1.13) |
| West | 0.97 (0.75, 1.26) | 0.97 (0.88, 1.07) | 1.16 (0.86, 1.56) | 0.91 (0.78, 1.06) |
| Received influenza vaccination | ||||
| Yes | 1.55 (1.31, 1.84) | 1.04 (0.97, 1.11) | 0.47 (0.37, 0.59) | NAf |
| Nod | Reference | Reference | Reference | NA |
| Knowledge of recommendation for influenza vaccination | ||||
| Yes | NA | NA | NA | 1.33 (1.19, 1.48) |
| Nod | NA | NA | NA | Reference |
| Visit to healthcare professional/received recommendation/offer for influenza vaccination | ||||
| Doctor visit/received recommendation/offered influenza vaccination | 0.84 (0.67, 1.07) | 1.10 (1.01, 1.20) | 0.87 (0.66, 1.13) | 1.91 (1.69, 2.17) |
| Doctor visit/received recommendation/not offered influenza vaccination | 1.01 (0.76, 1.33) | 1.06 (0.94, 1.19) | 0.82 (0.56, 1.20) | 1.37 (1.15, 1.63) |
| Doctor visit/not received recommendation/not offered influenza vaccination | 0.94 (0.77, 1.15) | 1.03 (0.95, 1.12) | 0.97 (0.78, 1.20) | 1.04 (0.90, 1.20) |
| Did not visit doctor or healthcare professionald | Reference | Reference | Reference | Reference |
| Metropolitan statistical area status | ||||
| Metro | 0.83 (0.66, 1.06) | 1.04 (0.94, 1.16) | 1.07 (0.82, 1.40) | 0.98 (0.85, 1.14) |
| Non-metrod | Reference | Reference | Reference | Reference |
| Children in household | ||||
| No Childrend | Reference | Reference | Reference | Reference |
| Children aged ≤5 years | 2.63 (2.01, 3.43) | 0.79 (0.65, 0.95) | 0.46 (0.25, 0.82) | 1.18 (0.95, 1.46) |
| Children aged 6–17 years | 1.92 (1.57, 2.36) | 0.90 (0.82, 1.00) | 0.66 (0.50, 0.88) | 0.87 (0.75, 1.01) |
| High-risk condition statusg | ||||
| With high-risk conditions | 1.20 (1.01, 1.43) | 1.02 (0.95, 1.10) | 0.76 (0.60, 0.95) | 1.15 (1.04, 1.28) |
| Without high-risk conditionsd | Reference | Reference | Reference | Reference |
Note: Boldface indicates significance (p < 0.05 comparing to the reference group).
Adults who answered “all persons age 6 months and older” to the survey question, “Who do you believe the flu vaccine is recommended for” were considered to have correct knowledge about the ACIP recommendation for influenza vaccination.
Adults who answered either “all persons age 13 years and older” or “only adults age 18 and older with chronic medical conditions” or “all persons age 6 years and older” or “persons of any age” to the survey question, “Who do you believe the flu vaccine is recommended for” were considered to have awareness that there was a recommendation for influenza vaccination, but did not indicate correct knowledge of the recommended age group.
Confidence interval.
Reference level.
Annual household income.
Not Applicable
Adults were considered having a high risk condition if they had ever been told by a doctor or other health professional that they had chronic asthma, a lung condition other than asthma, diabetes, heart disease (other than high blood pressure, heart murmur, or mitral valve prolapse), a kidney condition, a liver condition, obesity, sickle cell anemia or other anemia, a neurologic or neuromuscular condition that makes it difficult to cough, or a weakened immune system caused by chronic illness or by medicines taken for chronic illness such as cancer, chemotherapy, HIV/AIDS, steroids, and transplant medicines.
3. Results
Sociodemographic and access-to-care characteristics of the study population are shown in Table 1.
Table 1.
Demographic characteristics of adults aged 18 years and older, United States, National Internet Flu Survey 2015.
| Characteristic | Sample Size, Na |
Weighted Percentage, % |
|---|---|---|
| Total | 3301 | 100.0 |
| Age | ||
| 18–49 years | 1508 | 54.7 |
| 50–64 years | 1033 | 26.0 |
| 65 years and older | 760 | 19.3 |
| Gender | ||
| Male | 1622 | 48.3 |
| Female | 1679 | 51.7 |
| Race/ethnicity | ||
| Non-Hispanic white only | 1922 | 65.5 |
| Non-Hispanic black only | 494 | 11.8 |
| Hispanic | 460 | 14.1 |
| Non-Hispanic, other or multiple races | 425 | 8.6 |
| Marital status | ||
| Married/living with partner | 1950 | 57.9 |
| Widowed/divorced/separated | 616 | 17.7 |
| Never married | 735 | 24.5 |
| Education level | ||
| High school or less | 1161 | 41.4 |
| Some college | 956 | 28.5 |
| College degree or higher | 1184 | 30.1 |
| Employment | ||
| Employed | 1862 | 58.5 |
| Unemployed | 188 | 6.3 |
| Not in work force | 1251 | 35.2 |
| Annual incomeb | ||
| <$35,000 | 945 | 27.2 |
| $35,000–$49,999 | 374 | 11.6 |
| $50,000–$74,999 | 628 | 17.9 |
| $75,000+ | 1354 | 43.3 |
| Region of residence | ||
| Northeast | 590 | 18.1 |
| Midwest | 693 | 21.4 |
| South | 1185 | 37.1 |
| West | 833 | 23.4 |
| Received an influenza vaccination | ||
| Yes | 1354 | 39.9 |
| No | 1894 | 60.1 |
| Knowledge/awareness of recommendation for influenza vaccination | ||
| Correct knowledgec of recommendation | 645 | 19.6 |
| Awarenessd of recommendation | 2048 | 62.3 |
| Neither knowledge nor awareness of recommendation | 585 | 18.1 |
| Visit to healthcare professional/received recommendation/offer for flu vaccination | ||
| Doctor visit/received recommendation/offered flu vaccination | 661 | 19.7 |
| Doctor visit/received recommendation/not offered flu vaccination | 268 | 7.9 |
| Doctor visit/not received recommendation/not offered flu vaccination | 845 | 28.5 |
| Did not visit doctor or healthcare professional | 1229 | 43.9 |
| Metropolitan statistical area status | ||
| Metro | 2885 | 85.0 |
| Non-metro | 416 | 15.0 |
| Children in household | ||
| No Children | 2432 | 71.2 |
| Children aged ≤5 years | 175 | 5.6 |
| Children aged 6–17 years | 694 | 23.2 |
| High-risk condition statuse | ||
| With high-risk conditions | 1079 | 30.5 |
| Without high-risk conditions | 2222 | 69.5 |
Unweighted sample size.
Annual household income.
Adults who answered “all persons age 6 months and older” to the survey question, “Who do you believe the flu vaccine is recommended for” were considered to have correct knowledge about the ACIP recommendation for influenza vaccination.
Adults who answered either “all persons age 13 years and older” or “only adults age 18 and older with chronic medical conditions” or “all persons age 6 years and older” or “persons of any age” to the survey question, “Who do you believe the flu vaccine is recommended for” were considered to have awareness that there was a recommendation for influenza vaccination, but did not indicate correct knowledge of the recommended age group.
Adults were considered having a high-risk condition if they had ever been told by a doctor or other health professional that they had chronic asthma, a lung condition other than asthma, diabetes, heart disease (other than high blood pressure, heart murmur, or mitral valve prolapse), a kidney condition, a liver condition, obesity, sickle cell anemia or other anemia, a neurologic or neuromuscular condition that makes it difficult to cough, or a weakened immune system caused by chronic illness or by medicines taken for chronic illness such as cancer, chemotherapy, HIV/AIDS, steroids, and transplant medicines.
Among all adults aged ≥18 years, only 19.6% indicated correct knowledge of the influenza vaccination recommendation (those who answered that “the vaccine is recommended for all persons age 6 months and older”) (Table 2). Among those indicating correct knowledge of the influenza vaccination recommendation, influenza vaccination coverage was 53.5%, significantly higher than those with incorrect answers including, “only adults age 18 years and older with chronic medical conditions” (33.4%); “all persons age 6 years and older” (40.1%); “persons of any age” (39.4%); “none of the above” (16.6%); and “don’t know” (23.3%) (Table 2).
Table 2.
Influenza vaccination coverage and population distribution of responses to a question about knowledge of the influenza vaccination recommendation among adults aged ≥18 years by age group, United States, National Internet Flu Survey 2015.
| Sample Size |
Weighted Percentage |
Influenza Vaccination Coverage |
Age Group | |||
|---|---|---|---|---|---|---|
|
| ||||||
| Answer Responses | Na | % | % | 18–49 years N (%) | 50–64 years, N (%) | ≥65 years. N (%) |
| Total | 3301 | 100.0 | 39.9 | 1508 (54.7) | 1033 (26.0) | 760 (19.3) |
| Who do you believe flu vaccine is recommended for | ||||||
| All persons age 13 years and older | 367 | 11.2 | 47.7 | 157 (10.9) | 122 (12.3) | 88 (10.6)b |
| Only adults age 18 and older with chronic medical conditions | 146 | 4.5 | 33.4c | 56 (4.0) | 66 (6.4) | 24 (3.4) |
| All persons age 6 years and older | 356 | 10.5 | 40.1c | 157 (10.5) | 112 (10.4) | 87 (10.6) |
| All persons age 6 months and older | 645 | 19.6 | 53.6 | 299 (19.4) | 160 (15.9) | 186 (25.2) |
| Persons of any age | 1179 | 36.1 | 39.4c | 564 (37.3) | 372 (35.6) | 243 (33.4) |
| None of the above | 128 | 3.9 | 16.6c | 71 (4.7) | 36 (3.4) | 21 (2.5) |
| Don’t know | 457 | 14.2 | 23.3c | 187 (13.1) | 160 (16.2) | 110 (14.3) |
Unweighted sample size.
p < 0.05 by chi-square test among age groups.
p < 0.05 by t-test among those with all other responses compared with those who answered that “the vaccine is recommended for all persons age 6 months and older”.
In bi-variable analyses (Table 3), 62.3% reported being aware that influenza vaccination is recommended, and 18.1% reported having neither knowledge nor awareness of recommendation. Knowledge of the correct influenza vaccination recommendation was significantly higher (26.8%) among those who received vaccination compared with those who had not (15.4%) (Table 3). Overall, 39.9% of adults aged ≥18 years reported having an influenza vaccination by the date they completed the NIFS interview. The following factors were significantly associated with a higher level of correct knowledge of the influenza vaccination recommendation: age ≥65 years, being female, having a college or higher education, not being in the workforce, household income ≥$50,000, reporting having received an influenza vaccination early in the 2015–16 season, having children aged ≤17 years in the household, and having high-risk conditions (Table 3). Being in the 50–64 years age group, non-Hispanic black race/ethnicity, and never having been married were significantly associated with a lower level of correct knowledge of the influenza vaccination recommendation. Having children aged ≤17 years in the household was the common factor that was significantly associated with correct knowledge, awareness, and neither knowledge nor awareness of influenza vaccination recommendation. Other factors that were associated with knowledge or awareness, and neither knowledge nor awareness were shown in Table 3. The following factors were significantly associated with higher influenza vaccination coverage: age ≥50 years, having a college or higher education, not being in the workforce, indicating correct knowledge of influenza vaccination recommendation, reporting having visited a doctor or healthcare professional since July 1 and having received a recommendation with or without offer for vaccination, and having high-risk conditions. Being of non-Hispanic black race/ethnicity, never having been married, neither having correct knowledge nor awareness of influenza vaccination recommendation, and having children aged 6–17 years in the household were significantly associated with a lower coverage level of influenza vaccination (Table 3).
Table 3.
Knowledge and awareness of influenza vaccination recommendation and vaccination coverage among adults ≥18 years by demographic characteristics - United States, National Internet Flu Survey 2015.
| Knowledgea of influenza vaccination recommendation |
Awarenessb of influenza vaccination recommendation |
Neither knowledge nor awareness of influenza vaccination recommendation |
Early season influenza vaccination coverage |
|
|---|---|---|---|---|
| Characteristic | % (95% CIc) | % (95% CI) | % (95% CI) | % (95% CI) |
| Overall | 19.6 (18.1, 21.2) | 62.3 (60.3, 64.2) | 18.1 (16.6, 19.7) | 39.9 (38.0, 41.8) |
| Age | ||||
| 18–49 yearsd | 19.4 (17.2, 21.9) | 62.7 (59.7, 65.6) | 17.9 (15.6, 20.4) | 31.8 (29.1, 34.7) |
| 50–64 years | 15.9 (13.5, 18.6) | 64.6 (61.2, 67.8) | 19.6 (17.0, 22.4) | 41.3 (37.9, 44.7) |
| 65 years and older | 25.2 (21.9, 28.7) | 58.1 (54.1, 61.9) | 16.8 (14.0, 20.0) | 60.4 (56.4, 64.2) |
| Gender | ||||
| Maled | 15.4 (13.5, 17.6) | 62.6 (59.7, 65.4) | 22.0 (19.6, 24.5) | 37.9 (35.2, 40.7) |
| Female | 23.5 (21.2, 26.0) | 62.0 (59.2, 64.7) | 14.5 (12.6, 16.6) | 41.7 (38.9, 44.5) |
| Race/ethnicity | ||||
| Non-Hispanic white onlyd | 21.5 (19.5, 23.5) | 60.1 (57.7, 62.5) | 18.4 (16.5, 20.4) | 41.6 (39.2, 44.0) |
| Non-Hispanic black only | 13.8 (10.6, 17.7) | 67.3 (62.1, 72.1) | 18.9 (15.1, 23.4) | 35.5 (30.4, 40.9) |
| Hispanic | 17.8 (13.5, 23.2) | 65.4 (59.3, 71.1) | 16.8 (12.6, 22.0) | 36.8 (31.0, 42.9) |
| Non-Hispanic, other or multiple races | 16.2 (11.9, 21.7) | 66.9 (60.4, 72.9) | 16.8 (12.4, 22.4) | 37.9 (31.7, 44.6) |
| Marital status | ||||
| Married/living with partnerd | 22.2 (20.1, 24.4) | 61.1 (58.6, 63.7) | 16.7 (14.8, 18.8) | 42.6 (40.1, 45.1) |
| Widowed/divorced/separated | 21.3 (17.7, 25.4) | 61.0 (56.4, 65.5) | 17.7 (14.5, 21.4) | 46.1 (41.5, 50.9) |
| Never married | 12.3 (9.7, 15.4) | 66.0 (61.7, 70.1) | 21.7 (18.2, 25.7) | 28.6 (24.9, 32.7) |
| Education level | ||||
| High school or lessd | 16.5 (14.1, 19.2) | 63.5 (60.2, 66.8) | 19.9 (17.3, 22.8) | 37.7 (34.5, 41.0) |
| Some college | 18.7 (15.9, 21.8) | 62.7 (59.0, 66.3) | 18.6 (15.8, 21.8) | 35.9 (32.4, 39.5) |
| College degree or higher | 24.7 (22.0, 27.6) | 60.2 (56.9, 63.3) | 15.1 (13.0, 17.6) | 46.6 (43.4, 49.9) |
| Employment | ||||
| Employedd | 18.7 (16.7, 20.9) | 63.1 (60.4, 65.6) | 18.3 (16.2, 20.5) | 36.2 (33.7, 38.7) |
| Unemployed | 14.1 (8.6, 22.0) | 71.6 (63.1, 78.8) | 14.3 (9.7, 20.7) | 28.7 (21.3, 37.5) |
| Not in work force | 22.1 (19.6, 24.9) | 59.4 (56.1, 62.5) | 18.5 (16.0, 21.2) | 47.9 (44.6, 51.2) |
| Annual incomee | ||||
| <$35,000d | 15.1 (12.6, 18.0) | 60.9 (57.0, 64.8) | 23.9 (20.6, 27.6) | 36.8 (33.0, 40.7) |
| $35,000–$49,999 | 19.5 (14.9, 25.0) | 62.7 (56.6, 68.5) | 17.8 (13.6, 22.9) | 38.6 (32.8, 44.7) |
| $50,000–$74,999 | 19.8 (16.4, 23.8) | 64.7 (60.1, 69.1) | 15.4 (12.3, 19.2) | 42.3 (37.8, 46.9) |
| $75,000+ | 22.3 (19.9, 25.0) | 62.0 (59.0, 64.9) | 15.7 (13.6, 18.0) | 41.2 (38.3, 44.1) |
| Region of residence | ||||
| Northeastd | 18.4 (15.1, 22.3) | 65.5 (60.9, 69.8) | 16.1 (12.9, 19.9) | 41.6 (37.0, 46.4) |
| Midwest | 20.0 (16.8, 23.7) | 59.1 (54.8, 63.3) | 20.9 (17.6, 24.6) | 42.7 (38.5, 46.9) |
| South | 20.8 (18.2, 23.6) | 61.6 (58.3, 64.9) | 17.6 (15.1, 20.5) | 39.6 (36.3, 42.9) |
| West | 18.3 (15.4, 21.7) | 63.8 (59.8, 67.7) | 17.9 (15.0, 21.2) | 36.5 (32.7, 40.5) |
| Received influenza vaccination | ||||
| Yes | 26.8 (24.1, 29.6) | 63.6 (60.6, 66.6) | 9.6 (8.0, 11.6) | NAf |
| Nod | 15.4 (13.6, 17.5) | 61.7 (59.0, 64.3) | 22.9 (20.7, 25.3) | NA |
| Knowledge of recommendation for influenza vaccination | ||||
| Yes | NA | NA | NA | 53.5 (49.0, 58.0) |
| Nod | NA | NA | NA | 36.5 (34.4, 38.6) |
| Awareness of recommendation for influenza vaccination | ||||
| Yes | NA | NA | NA | 40.6 (38.2, 43.1) |
| Nod | NA | NA | NA | 38.6 (35.5, 41.8) |
| Neither knowledge nor awareness of recommendation for influenza vaccination | ||||
| Yes | NA | NA | NA | 21.8 (18.2, 25.9) |
| Nod | NA | NA | NA | 43.7 (41.6, 45.9) |
| Visit to healthcare professional/received recommendation/offer for influenza vaccination | ||||
| Doctor visit/received recommendation/offered influenza vaccination | 20.8 (17.3, 24.8) | 66.2 (61.8, 70.4) | 13.0 (10.3, 16.4) | 64.7 (60.3, 69.0) |
| Doctor visit/received recommendation/not offered influenza vaccination | 21.3 (16.2, 27.3) | 64.8 (58.0, 71.0) | 14.0 (9.7, 19.6) | 47.8 (41.1, 54.6) |
| Doctor visit/not received recommendation/not offered influenza vaccination | 20.5 (17.5, 23.9) | 62.5 (58.7, 66.2) | 17.0 (14.3, 20.1) | 33.4 (29.9, 37.2) |
| Did not visit doctor or healthcare professionald | 19.1 (16.7, 21.8) | 61.0 (57.7, 64.2) | 19.9 (17.3, 22.7) | 29.5 (26.6, 32.6) |
| Metropolitan statistical area status | ||||
| Metro | 19.3 (17.7, 21.0) | 62.8 (60.7, 64.9) | 17.9 (16.2, 19.7) | 40.0 (38.0, 42.2) |
| Non-metrod | 21.3 (17.0, 26.4) | 59.4 (53.9, 64.7) | 19.3 (15.4, 23.9) | 39.0 (33.8, 44.4) |
| Children in household | ||||
| No Childrend | 16.0 (14.4, 17.6) | 64.1 (61.8, 66.3) | 20.0 (18.1, 21.9) | 42.5 (40.3, 44.8) |
| Children aged ≤5 years | 38.0 (29.9, 46.8) | 50.0 (41.2, 58.8) | 12.0 (7.3, 19.2) | 43.5 (34.9, 52.6) |
| Children aged 6–17 years | 26.3 (22.5, 30.6) | 59.8 (55.3, 64.1) | 13.9 (11.1, 17.3) | 30.8 (27.0, 35.0) |
| High-risk condition statusg | ||||
| With high-risk conditions | 22.4 (19.5, 25.5) | 64.5 (61.0, 67.8) | 13.2 (11.1, 15.6) | 49.1 (45.6, 52.6) |
| Without high-risk conditionsd | 18.4 (16.6, 20.3) | 61.3 (58.9, 63.7) | 20.3 (18.3, 22.4) | 35.8 (33.5, 38.2) |
Note: Boldface indicates significance (p < 0.05 comparing to the reference group).
Adults who answered “all persons age 6 months and older” to the survey question, “Who do you believe the flu vaccine is recommended for” were considered to have correct knowledge about the ACIP recommendation for influenza vaccination.
Adults who answered either “all persons age 13 years and older” or “only adults age 18 and older with chronic medical conditions” or “all persons age 6 years and older” or “persons of any age” to the survey question, “Who do you believe the flu vaccine is recommended for” were considered to have awareness that there was a recommendation for influenza vaccination, but did not indicate correct knowledge of the recommended age group.
Confidence interval.
Reference level.
Annual household income.
Not Applicable.
Adults were considered having a high risk condition if they had ever been told by a doctor or other health professional that they had chronic asthma, a lung condition other than asthma, diabetes, heart disease (other than high blood pressure, heart murmur, or mitral valve prolapse), a kidney condition, a liver condition, obesity, sickle cell anemia or other anemia, a neurologic or neuromuscular condition that makes it difficult to cough, or a weakened immune system caused by chronic illness or by medicines taken for chronic illness such as cancer, chemotherapy, HIV/AIDS, steroids, and transplant medicines.
In multivariable analyses, among adults ≥18 years, the following factors were significantly associated with a higher level of correct knowledge of influenza vaccination recommendation: age ≥65 years, being female, having a college or higher education, not being in work force, having annual household income ≥$75,000, reporting having received an influenza vaccination early in the 2015–16 season, having children aged ≤17 years in the household, and having one or more high-risk conditions. Being of non-Hispanic black race/ethnicity was significantly associated with a lower level of correct knowledge of influenza vaccination recommendation (Table 4). Having children aged ≤17 years in the household was the common factor that was significantly associated with correct knowledge, awareness, and neither knowledge nor awareness of influenza vaccination recommendation. Other factors that were associated with awareness and neither knowledge nor awareness were shown in Table 4. Among adults ≥18 years, the following factors were significantly associated with a higher level of influenza vaccination: age ≥50 years, having a college or higher education, indicating knowledge of influenza vaccination recommendation, reporting having visited a doctor or healthcare professional since July 1 and having received a recommendation with or without offer for vaccination, and having high-risk conditions (Table 4).
4. Discussion
Less than 1 in 5 adults in the United States had correct knowledge of the ACIP recommendation that all persons aged ≥6 months should receive an influenza vaccination annually, with some socio-economic groups being even less knowledgeable. However, more than 3 in 5 adults in the United States were aware that there is a recommendation for influenza vaccination, although they did not know the correct recommended age group. Less than half of adults reported vaccination by early November 2015. Since 2010, annual influenza vaccination recommendation has been recommended for all persons 6 months of age and older [1]. To our knowledge, this is the first comprehensive assessment of knowledge of the influenza vaccination recommendation, providing data on associations with the sociodemographic characteristics. Such information can assist efforts to develop strategies to improve knowledge and vaccination coverage among adult populations.
Overall, based on our study, 39.9% of adults aged ≥18 years reported having an influenza vaccination by the date they completed their survey. Vaccination coverage increases by the end of season; however, increases are limited, since most people receive their vaccination before December with only about 8% of individuals being vaccinated from December through May [21]. Although influenza vaccination was recommended to all adults aged ≥18 years since 2010–11 season, coverage was low by 2015 based on our study. Increased influenza vaccination coverage among adult populations is needed. Strategies to increase vaccination coverage include assessment of patients’ vaccination indications by healthcare providers and routine recommendation and offer of needed vaccines to adults, implementation of client reminder-recall systems, and use of provider reminders for vaccination [22,25–30].
This study showed that age ≥50 years, having a college or higher education, and having high-risk conditions were significantly associated with influenza vaccination, consistent with other studies [25,26]. Reporting having visited a doctor or healthcare professional and having received a recommendation with or without offer for vaccination were significantly associated with influenza vaccination, suggesting that receiving a recommendation for vaccination from a healthcare provider plays an important role in early season influenza vaccine uptake, and an offer can increase the likelihood of vaccination uptake. Provider reminders can help ensure a provider remembers to recommend vaccination. Additionally, knowledge of the influenza vaccination recommendation was significantly associated with influenza vaccination after controlling for other factors, highlighting the importance of knowledge in efforts to increase vaccination coverage.
Overall, only 19.6% indicated correct knowledge that influenza vaccination is recommended for all persons aged ≥6 months. This rate is low given that influenza is one of the most common infectious diseases that causes substantial morbidity and mortality among adults in the United States. Additionally, universal influenza vaccination recommendation was widely covered by media when CDC launched the new recommendation in 2010. Furthermore, CDC invests in a national awareness campaign annually to educate the general population about the importance of influenza vaccination through a mix of communication channels and in collaboration with national and grass-root partners (e.g., local faith-based or community-based organizations who coordinating immunization clinics) who organize influenza promotion activities and events [1,31,32]. Approximately 36.0% of adults answered that “persons of any age” are recommended to receive influenza vaccination, which indicated that some individuals might be confused with the correct recommendation of “all persons aged ≥6 months”. The lower knowledge of influenza vaccination recommendation observed in this study (19.6%) could be compared with findings from an influenza A (H1N1) 2009 monovalent vaccine (pH1N1 vaccine) study, which also indicated low knowledge of influenza vaccination recommendations [23]. In that study, only 29.5% of recommended adults correctly reported being in the target groups recommended to receive the pH1N1 vaccine, despite comprehensive media coverage in the wake of the influenza A (H1N1) pandemic and distribution of the pH1N1 vaccine [23]. Several characteristics were independently associated with correct knowledge or awareness of the influenza vaccination recommendation after controlling for other factors. Both female gender and higher education were associated with correct knowledge, which is consistent with previous studies [33–39]. This findings are important for identifying intervention programs to improve awareness among those groups. Efforts to better educate men and those with lower levels of education about influenza vaccination recommendation might improve vaccination.
Having children aged ≤17 years in the household was associated with knowledge of the correct influenza vaccination recommendation. Adults without children in the households might pay less attention to the details of influenza vaccination recommendations and focus on and remember what applies to themselves. Adults with children in the household have more contact with healthcare providers, and in general have more opportunities to discuss vaccination recommendations with providers, and provider recommendation has been previously shown to influence vaccine uptake [40–43], which might explain the observed association between having children in the household with correct knowledge of the influenza vaccination recommendation. In addition, adults with children, especially small children in the household are likely to have an increased uptake of influenza vaccination to protect their children.
Fewer Non-Hispanic black adults had correct knowledge of the influenza vaccination recommendation compared with non-Hispanic white adults. Similar significant racial/ethnic differences among adults in knowledge of other recommended vaccines such as herpes zoster vaccination [44] and human papillomavirus vaccination have been previously reported [36,39,45,46]. This finding might reflect lower prevalence of vaccination services being offered to black patients, and lower knowledge levels can limit the ability of patients to request vaccination when appropriate [36,39,45,46]. A lack of knowledge regarding recommended vaccinations could translate into a missed opportunity for protection against vaccine preventable diseases. Since patients may not seek vaccination services, each provider visit, including non-routine visits, is a critical opportunity to ensure provider implementation of vaccination services, assessing vaccination needs and recommending necessary adult vaccines to protect adult patients and improve coverage. Clinic based education in combination with strategies known to increase uptake of recommended vaccines, such as patient reminder/recall systems and other healthcare system-based interventions are needed to improve vaccination, which could also improve awareness.
Having received an influenza vaccination early in the 2015–16 season was independently associated with correct knowledge of the influenza vaccination recommendation, indicating that vaccination coverage might be related to knowledge of the recommendation. Additionally, among those who answered “None of the above (listed answers)” or “Don’t know” had particularly lower influenza vaccination coverage (16.6%, and 23.3%, respectively), indicating that lack of knowledge and awareness of the recommendation is related to lower vaccination coverage. In addition, our study showed that more persons with high-risk conditions had correct knowledge of the influenza vaccination recommendation compared to persons without a high-risk condition. Persons with high-risk conditions have more frequent physician contact and more opportunities to discuss their health status and vaccination indications with their providers. Future interventions targeting healthcare providers could help increase influenza vaccine acceptability and uptake. For example, physician vaccination reminder systems may help increase vaccination coverage but are underused by healthcare providers [47,48].
The findings in this study are subject to two limitations. Data for this study were collected by self-report and vaccination was not verified by medical records and may be subject to recall bias [49]. Estimates based on self-report may over or underestimate vaccination coverage. However, self-reported influenza vaccination status among adults has been shown to be sensitive and specific with vaccination status ascertained from medical records [50]. Second, NIFS is an Internet panel survey and although the Internet panel was probability-based, the estimates may not represent all adults in the United States (for example, the response rate is 57.6% and non-responders existed, and the institutionalized adult populations were excluded from the survey), and bias may remain after the weighting adjustments [51]. This limitation may over- or under-estimate vaccination coverage. Third, the representativeness of the respondents which appear to make up of a considerably high number of non-Hispanic white only, household income ≥$75,000, and living in the South, which may also have impact on our results. Finally, this findings is based on a single year survey only, monitoring the future knowledge and coverage levels are necessary.
Overall, less than half of adults reported vaccination by early November. Five years have passed since ACIP recommended annual influenza vaccination in the 2010–11 season to all persons aged ≥6 months, only less than 1 in 5 adults in the United States had knowledge of this influenza vaccination recommendation in 2015, with some socio-economic groups being even less knowledgeable. Increasing demand for vaccinations through client reminder and recall systems or clinic-based education with expanded access across all healthcare settings, including pharmacies, may help improve knowledge of influenza vaccination recommendation and increase vaccination coverage [28,52].
Acknowledgments
We thank James A. Singleton and Stacie M. Greby for their thoughtful review of the manuscript.
Footnotes
Conflict of interest
All authors have no conflicts of interest to be stated.
Disclaimer
The findings and conclusions in this paper are those of the authors and do not necessarily represent the views of CDC.
References
- 1.Centers for Disease Control and Prevention (CDC) Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR. 2010;59(RR08):1–62. [Google Scholar]
- 2.Centers for Disease Control and Prevention (CDC) [[accessed January 12, 2017]];Estimated influenza illnesses, medical visits, hospitalizations, and deaths averted by vaccination in the United States. Available at: < https://www.cdc.gov/flu/about/disease/2015-16.htm>.
- 3.Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalization in the United States. JAMA. 2004;292:1333–40. doi: 10.1001/jama.292.11.1333. [DOI] [PubMed] [Google Scholar]
- 4.Bridges CB, Katz JM, Levandowski RL, Cox NJ. Inactivated influenza vaccine. Vaccines. (5) 2007:259–90. [Google Scholar]
- 5.Bridges CB, Thompson WW, Meltzer MI, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA. 2000;284:1655–63. doi: 10.1001/jama.284.13.1655. [DOI] [PubMed] [Google Scholar]
- 6.Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25:5086–96. doi: 10.1016/j.vaccine.2007.03.046. [DOI] [PubMed] [Google Scholar]
- 7.Mullooly JP, Bridges CB, Thompson WW, Chen J, Weintraub E, Jackson LA, et al. Influenza- and RSV-associated hospitalizations among adults. Vaccine. 2007;25:846–55. doi: 10.1016/j.vaccine.2006.09.041. [DOI] [PubMed] [Google Scholar]
- 8.Kissling E, Valenciano M I-MOVE case-control studies team. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicenter case-control study, 2011/12. Euro Surveill. 2012;17(15):20146. [PubMed] [Google Scholar]
- 9.Jimenez-Jorge S, de Mateo S, Pozo F, et al. Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012. Euro Surveill. 2012;17(12):20129. [PubMed] [Google Scholar]
- 10.Vu T, Farish S, Jenkins M, Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine. 2002;20:1831–6. doi: 10.1016/s0264-410x(02)00041-5. [DOI] [PubMed] [Google Scholar]
- 11.Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals A randomized double-blind placebo-controlled trial. JAMA. 1994;272(21):1661–5. [PubMed] [Google Scholar]
- 12.Gatwood J, Meltzer MI, Messonnier M, Ortega-Sanchez IR, Balkrishnan R, Prosser LA. Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations. Drugs. 2012;72(1):35–48. doi: 10.2165/11597310-000000000-00000. [DOI] [PubMed] [Google Scholar]
- 13.Fireman B, Lee J, Lewis N, Bembom O, van der Laan M, Baxter R. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol. 2009;170(5):650–6. doi: 10.1093/aje/kwp173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Fedson DS, Houck P, Bratzler D. Hospital-based influenza and pneumococcal vaccination: Sutton’s law applied to prevention. Infect Control Hosp Epidemiol. 2000;21:692–9. doi: 10.1086/501716. [DOI] [PubMed] [Google Scholar]
- 15.Ohmit SE, Victor JC, Rotthoff JR, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med. 2006;355:2513–22. doi: 10.1056/NEJMoa061850. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Baguelin M, Jit M, Miller E, Edmunds WJ. Health and economic impact of the seasonal influenza vaccination programme in England. Vaccine. 2012;30(23):3459–62. doi: 10.1016/j.vaccine.2012.03.019. [DOI] [PubMed] [Google Scholar]
- 17.Williams WW. Managed care can improve pneumococcal and influenza vaccination levels. HMO Pract. 1997;2(4):174–5. [PubMed] [Google Scholar]
- 18.Fedson DS. Adult immunization: summary of the national vaccine advisory committee report. JAMA. 1994;272:1133–7. doi: 10.1001/jama.272.14.1133. [DOI] [PubMed] [Google Scholar]
- 19.Centers for Disease Control and Prevention (CDC) Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR. 2009;58(RR08):1–52. [Google Scholar]
- 20.Williams WW, Lu PJ, O’Halloran A, et al. Surveillance of vaccination coverage among adult populations – United States, 2014. MMWR Surveill Summ. 2016;65(SS-1):1–36. doi: 10.15585/mmwr.ss6501a1. [DOI] [PubMed] [Google Scholar]
- 21.Centers for Disease Control and Prevention (CDC) [[accessed April 15, 2016]];FluVaxView. Available at: < http://www.cdc.gov/flu/fluvaxview/>.
- 22.Lu PJ, Santibanez TA, Williams WW, et al. Surveillance of influenza vaccination coverage - United States, 2007–08 through 2011–12 influenza seasons. MMWR Surveill Summ. 2013;62(SS-4):1–29. [PubMed] [Google Scholar]
- 23.Maurer J, Uscher-Pines L, Harris KM. Awareness of government seasonal and pH1N1 influenza vaccination recommendations among targeted US adults: the role of provider interactions. Am J Infect Control. 2010;38(6):489–90. doi: 10.1016/j.ajic.2010.04.210. [DOI] [PubMed] [Google Scholar]
- 24. [[accessed April 21, 2016]];Knowledge Panel. Available at: < http://www.knowledgenetworks.com/ganp/docs/KnowledgePanel(R)-Design-Summary.pdf>.
- 25.Lu PJ, O’Halloran A, Ding H, Srivastav A, Williams WW. Uptake of influenza vaccination and missed opportunities among adults with high risk conditions, United States, 2013. Am J Med. 2015 doi: 10.1016/j.amjmed.2015.10.031. pii: S0002-9343(15)01036-0. [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Lu PJ, O’Halloran A, Williams WW, Lindley MC, Farrall S, Bridges CB. Racial and ethnic disparities in vaccination coverage among adult populations – United States, 2012. Am J Prev Med. 2015;49(6S4):S412–25. doi: 10.1016/j.amepre.2015.03.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.National Vaccine Advisory Committee. Recommendations from the National Vaccine Advisory Committee: standards for adult immunization practice. Public Health Rep. 2014;129(2):115–23. doi: 10.1177/003335491412900203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. [[accessed May 3, 2016]];Guide to Community Preventive Services. Available at: < http://www.thecommunityguide.org/index.html>.
- 29.Hurley LP, Bridges CB, Harpaz R, et al. U.S. physician’s perspective of adult vaccine delivery. Ann Intern Med. 2014;160:161–70. doi: 10.7326/M13-2332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Johnson DR, Nichol KL, Lipczynski K. Barriers to adult immunization. Am J Med. 2008;121(7B):S28–35. doi: 10.1016/j.amjmed.2008.05.005. [DOI] [PubMed] [Google Scholar]
- 31.Centers for Disease Control and Prevention (CDC) [[accessed May 3, 2016]];CDC national influenza vaccine awareness campaign. Available at: < http://www.cdc.gov/flu/pdf/nivw/nivw-media-toolkit.pdf>.
- 32. [ [accessed May 3,2016]]; Available at: < http://www.cidrap.umn.edu/news-perspective/2010/07/cdc-launches-universal-flu-vaccination-recommendation>.
- 33.Lu PJ, O’Halloran A, Williams WW. Impact of health insurance status on vaccination coverage among adult populations - United States, 2012. Am J Prev Med. 2015;48(6):647–61. doi: 10.1016/j.amepre.2014.12.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Vaidya V, Partha G, Karmakar M. Gender differences in utilization of preventive care services in the United States. J Womens Health (Larchmt) 2012;21(2):140–5. doi: 10.1089/jwh.2011.2876. [DOI] [PubMed] [Google Scholar]
- 35.Javed S, Javed F, Mays RM, Tyring SK. Herpes zoster vaccine awareness among people ≥50 years of age and its implications on immunization. Dermatol Online J. 2012;18(8):2. [PubMed] [Google Scholar]
- 36.Jain N, Euler GL, Shefer A, Lu PJ, Yankey D, Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Prev Med. 2009;48(5):426–31. doi: 10.1016/j.ypmed.2008.11.010. [DOI] [PubMed] [Google Scholar]
- 37.Miller BL, Kretsinger K, Euler GL, Lu PJ, Ahmed F. Barriers to early uptake of tetanus, diphtheria and acellular pertussis vaccine (Tdap) among adults-United States, 2005–2007. Vaccine. 2011;29(22):3850–6. doi: 10.1016/j.vaccine.2011.03.058. [DOI] [PubMed] [Google Scholar]
- 38.Lu PJ, Euler GL, Jumaan AO, Harpaz R. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors. Vaccine. 2009;27(6):882–7. doi: 10.1016/j.vaccine.2008.11.077. [DOI] [PubMed] [Google Scholar]
- 39.Pierre Joseph N, Clark JA, Mercilus G, Wilbur M, Figaro J, Perkins R. Racial and ethnic differences in HPV knowledge, attitudes, and vaccination rates among low-income African-American, Haitian, Latina, and Caucasian young adult women. J Pediatr Adolesc Gynecol. 2014;27(2):83–92. doi: 10.1016/j.jpag.2013.08.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Flood EM, Rousculp MD, Ryan KJ, et al. Parents’ decision-making regarding vaccinating their children against influenza: a web-based survey. Clin Ther. 2010;32:1448–67. doi: 10.1016/j.clinthera.2010.06.020. [DOI] [PubMed] [Google Scholar]
- 41.Daley MF, Crane LA, Chandramouli V, et al. Influenza among healthy young children: changes in parental attitudes and predictors of immunization during the 2003 to 2004 influenza season. Pediatrics. 2006;117(2):e268–77. doi: 10.1542/peds.2005-1752. [DOI] [PubMed] [Google Scholar]
- 42.Lin CJ, Zimmerman RK, Nowalk MP, et al. Parental perspectives on influenza vaccination of children with chronic medical conditions. J Natl Med Assoc. 2006;98:148–53. [PMC free article] [PubMed] [Google Scholar]
- 43.Soyer OU, Hudaverdiyev S, Civelek E, et al. Parental perspectives on influenza vaccination in children with asthma. Pediatr Pulmonol. 2011;46:139–44. doi: 10.1002/ppul.21332. [DOI] [PubMed] [Google Scholar]
- 44.Joon Lee T, Hayes S, Cummings DM, et al. Herpes zoster knowledge, prevalence, and vaccination rate by race. J Am Board Fam Med. 2013;26(1):45–51. doi: 10.3122/jabfm.2013.01.120154. [DOI] [PubMed] [Google Scholar]
- 45.Mehta NR, Julian PJ, Meek JI, et al. Human papillomavirus vaccination history among women with precancerous cervical lesions: disparities and barriers. Obstet Gynecol. 2012;119(3):575–81. doi: 10.1097/AOG.0b013e3182460d9f. [DOI] [PubMed] [Google Scholar]
- 46.Gelman A, Nikolajski C, Schwarz EB, Borrero S. Racial disparities in awareness of the human papillomavirus. J Womens Health (Larchmt) 2011;20(8):1165–73. doi: 10.1089/jwh.2010.2617. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Briss PA, Rodewald LE, Hinman AR, et al. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med. 2000;18(1 Suppl):97–140. doi: 10.1016/s0749-3797(99)00118-x. [DOI] [PubMed] [Google Scholar]
- 48.Tierney CD, Yusuf H, McMahon SR, et al. Adoption of reminder and recall messages for immunizations by pediatricians and public health clinics. Pediatrics. 2003;112(5):1076–82. doi: 10.1542/peds.112.5.1076. [DOI] [PubMed] [Google Scholar]
- 49.Lavrakas PJ. Encyclopedia of survey research methods. California: SAGE Publications Inc; 2008. [Google Scholar]
- 50.Rolnick SJ, Parker ED, Nordin JD, et al. Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors? Vaccine. 2013;31(37):3928–35. doi: 10.1016/j.vaccine.2013.06.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Valliant R, Dever JA, Kreuter F. Practical tools for designing and weighting sample surveys. New York: Springer; 2013. [Google Scholar]
- 52.Centers for Disease Control and Prevention (CDC) [[accessed May 5, 2016]];Recognizing National Immunization Awareness Month (NIAM) Available at: < http://www.cdc.gov/vaccines/events/niam.html>.
